Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Identifying Modifiable PAtient Centered Therapeutics Frailty: An Observational Cohort Study

Authors not listed

University of California, Los Angeles · 2023

Abstract

Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-07-02 MST

Cite this

APA
Anonymous. (2023). Identifying Modifiable PAtient Centered Therapeutics Frailty: An Observational Cohort Study. <em>University of California, Los Angeles</em>. https://clinicaltrials.gov/study/NCT04717869
Vancouver
Anonymous. Identifying Modifiable PAtient Centered Therapeutics Frailty: An Observational Cohort Study. University of California, Los Angeles. 2023.
BibTeX
@misc{anon2023Identi, title = {Identifying Modifiable PAtient Centered Therapeutics Frailty: An Observational Cohort Study}, author = {Anonymous}, journal = {University of California, Los Angeles}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.